Literature DB >> 20647011

Trypanosoma cruzi: insights into naphthoquinone effects on growth and proteinase activity.

Saulo C Bourguignon1, Danielle F B Cavalcanti, Alessandra M T de Souza, Helena C Castro, Carlos R Rodrigues, Magaly G Albuquerque, Dilvani O Santos, Gabriel Gomes da Silva, Fernando C da Silva, Vitor F Ferreira, Rosa T de Pinho, Carlos R Alves.   

Abstract

In this study we compared the effects of naphthoquinones (α-lapachone, β-lapachone, nor-β-lapachone and Epoxy-α-lap) on growth of Trypanosoma cruzi epimastigotes forms, and on viability of VERO cells. In addition we also experimentally analyzed the most active compounds inhibitory profile against T. cruzi serine- and cysteine-proteinases activity and theoretically evaluated them against cruzain, the major T. cruzi cysteine proteinase by using a molecular docking approach. Our results confirmed β-lapachone and Epoxy-α-lap with a high trypanocidal activity in contrast to α-lapachone and nor-β-lapachone whereas Epoxy-α-lap presented the safest toxicity profile against VERO cells. Interestingly the evaluation of the active compounds effects against T. cruzi cysteine- and serine-proteinases activities revealed different targets for these molecules. β-Lapachone is able to inhibit the cysteine-proteinase activity of T. cruzi proteic whole extract and of cruzain, similar to E-64, a classical cysteine-proteinase inhibitor. Differently, Epoxy-α-lap inhibited the T. cruzi serine-proteinase activity, similar to PMSF, a classical serine-proteinase inhibitor. In agreement to these biological profiles in the enzymatic assays, our theoretical analysis showed that E-64 and β-lapachone interact with the cruzain specific S2 pocket and active site whereas Epoxy-α-lap showed no important interactions. Overall, our results infer that β-lapachone and Epoxy-α-lap compounds may inhibit T. cruzi epimastigotes growth by affecting T. cruzi different proteinases. Thus the present data shows the potential of these compounds as prototype of protease inhibitors on drug design studies for developing new antichagasic compounds.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647011     DOI: 10.1016/j.exppara.2010.07.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.132


  9 in total

1.  Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.

Authors:  Franklin Souza-Silva; Saulo Cabral Bourguignon; Bernardo Acácio Santini Pereira; Luzia Monteiro de Castro Côrtes; Luiz Filipe Gonçalves de Oliveira; Andrea Henriques-Pons; Lea Cysne Finkelstein; Vitor Francisco Ferreira; Paula Fernandes Carneiro; Rosa Teixeira de Pinho; Ernesto Raul Caffarena; Carlos Roberto Alves
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Why strategies to control Leishmania spp. multiplication based on the use of proteinase inhibitors should consider multiple targets and not only a single enzyme.

Authors:  Carlos Roberto Alves; Bernardo Acácio Santini Pereira; Mariana Silva-Almeida; Franklin Souza da Silva
Journal:  J Mol Model       Date:  2014-10-09       Impact factor: 1.810

3.  Inactivation of β-Lapachone Cytotoxicity by Filamentous Fungi that Mimic the Human Blood Metabolism.

Authors:  Camila Raquel Paludo; Eduardo Afonso da Silva-Junior; Eliane de Oliveira Silva; Ricardo Vessecchi; Norberto Peporine Lopes; Mônica Tallarico Pupo; Flavio da Silva Emery; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.569

4.  Synthesis and antiplatelet activity of antithrombotic thiourea compounds: biological and structure-activity relationship studies.

Authors:  André Luiz Lourenço; Max Seidy Saito; Luís Eduardo Gomes Dorneles; Gil Mendes Viana; Plínio Cunha Sathler; Lúcia Cruz de Sequeira Aguiar; Marcelo de Pádula; Thaisa Francielle Souza Domingos; Aline Guerra Manssour Fraga; Carlos Rangel Rodrigues; Valeria Pereira de Sousa; Helena Carla Castro; Lucio Mendes Cabral
Journal:  Molecules       Date:  2015-04-20       Impact factor: 4.411

Review 5.  Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery.

Authors:  Felipe Raposo Passos Mansoldo; Fabrizio Carta; Andrea Angeli; Veronica da Silva Cardoso; Claudiu T Supuran; Alane Beatriz Vermelho
Journal:  Molecules       Date:  2020-11-23       Impact factor: 4.411

6.  Novel Solid Dispersions of Naphthoquinone Using Different Polymers for Improvement of Antichagasic Activity.

Authors:  Verônica da Silva Oliveira; Elen Diana Dantas; Anna Thereza de Sousa Queiroz; Johny Wysllas de Freitas Oliveira; Marcelo de Sousa da Silva; Patricia Garcia Ferreira; Fernando de Carvalho da Siva; Vitor Francisco Ferreira; Ádley Antonini Neves de Lima
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

7.  In Silico Insights into the Mechanism of Action of Epoxy-α-Lapachone and Epoxymethyl-Lawsone in Leishmania spp.

Authors:  Juliana Figueiredo Peixoto; Adriane da Silva Oliveira; Patrícia Queiroz Monteiro; Luiz Filipe Gonçalves-Oliveira; Valter Viana Andrade-Neto; Vitor Francisco Ferreira; Franklin Souza-Silva; Carlos Roberto Alves
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

8.  Efficient Catalytic Oxidation of 3-Arylthio- and 3-Cyclohexylthio-lapachone Derivatives to New Sulfonyl Derivatives and Evaluation of Their Antibacterial Activities.

Authors:  Mariana F do C Cardoso; Ana T P C Gomes; Caroline Dos S Moreira; Mário M Q Simões; Maria G P M S Neves; David R da Rocha; Fernando de C da Silva; Catarina Moreirinha; Adelaide Almeida; Vitor F Ferreira; José A S Cavaleiro
Journal:  Molecules       Date:  2017-02-16       Impact factor: 4.927

9.  Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment.

Authors:  Luiz Filipe Gonçalves Oliveira; Franklin Souza-Silva; Luzia Monteiro de Castro Côrtes; Lea Cysne-Finkelstein; Mirian Cláudia de Souza Pereira; Francisco Odêncio de Oliveira Junior; Rosa Teixeira Pinho; Suzana Corte Real; Saulo Cabral Bourguignon; Vitor Francisco Ferreira; Carlos Roberto Alves
Journal:  Molecules       Date:  2018-04-10       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.